Publications by authors named "Natalia Petenko"

Claim this Profile
A
A phase III study to access the safety and efficacy of prolgolimab 250 mg fixed dose administered every 3 weeks versus prolgolimab 1 mg/kg every 2 weeks in patients with metastatic melanoma (FLAT).
Lev Demidov, Galina Kharkevich, Natalia Petenko, Vladimir Moiseenko, Svetlana Protsenko

Front Oncol· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-World Experience with Targeted Therapy in BRAF Mutant Advanced Melanoma Patients: Results from a Multicenter Retrospective Observational Study Advanced Melanoma in Russia (Experience) (ADMIRE).
Kristina V Orlova, Evgeniy V Ledin, Natalia V Zhukova, Rashida V Orlova, Elena V Karabina, Natalia N Petenko

Cancers (Basel)· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunological monitoring for prediction of clinical response to antitumor vaccine therapy.
Irina N Mikhaylova, Irina Zh Shubina, George Z Chkadua, Natalia N Petenko, Lidia F Morozova

Oncotarget· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase II, multicenter, uncontrolled trial of single-agent capecitabine in patients with non-clear cell metastatic renal cell carcinoma.
Ilya Tsimafeyeu, Lev Demidov, Galina Kharkevich, Natalia Petenko, Vladimir Galchenko

Am J Clin Oncol· June 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis